Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0001209191-23-007054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-03 | 2023-02-01 | RXRX | Secora Michael | CFO | A - Grant | $0.00 | +210.2K | 790.5K | +36% | $0 |
| D | 2023-02-03 | 2023-02-01 | RXRX | Secora Michael | CFO | F - Tax | $8.55 | -2,669 | 795.6K | -0.3% | -$22.8K |
| D | 2023-02-03 | 2023-02-01 | RXRX | Secora Michael | CFO | A - Grant | $0.00 | +404.9K | 404.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-02-01 | A | A | 7,735 | $0.00 | 798,237 | D | — | — | |
| 2 | Common | Class A Common Stock | 2023-02-01 | F | D | 2,669 | $8.55 | 795,568 | D | — | — | |
| 3 | Common | Class A Common Stock | 2023-02-01 | A | A | 202,428 | $0.00 | 790,502 | D | — | — | (F2) Includes 1,502 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2022. |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-02-01 | A | A | 404,857 | $0.00 | 404,857 | D | $8.55 · — to 2033-02-01 | 404,857 Class A Common Stock | (F5) The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. |